Similar Articles
981 Immunology of hepatocellular carcinoma
982 Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma
983 Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells
984 Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
985 Biological features and biomarkers in hepatocellular carcinoma
986 Optimal combination of antiangiogenic therapy for hepatocellular carcinoma
987 Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?
988 Current and future treatments for hepatocellular carcinoma
989 Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma
990 Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA